The following is a list of Access to Information requests processed by Health Canada. The list is not all-inclusive. The list contains requests completed for which documents have been retrieved or treated. The list is provided in chronological order, by month and year, and by request number. (Requests focusing on personal information or third party proprietary information are not included.)
If you wish to obtain a copy of the records released in response to these requests informally, you may contact the Access to Information and Privacy Division.
| Request # | Summary of Requests | Status of Completed Request | Number of Pages Disclosed |
|---|---|---|---|
| A-2010-00113 | All documents pertaining to any trade or consumer complaint filed against the following company: Flora Manufacturing & Distributing Ltd; specifically with respect to their sale, marketing, or advertising of foods or drug products, including natural health products. | Disclosed in part | 530 |
| A-2012-00965 | All written communication, emails, data and test results passing between Dow AgroSciences Canada Inc. and the Pest Management Regulatory Agency regarding the 2011 label amendment for the florasulam component of PrePass whereby the crop rotation restrictions were changed. | Disclosed in part | 338 |
| A-2012-01037 | All documents used by Health Canada officers to obtain the conclusion relative to Complaint 64164. Complaint filed on May 3, 2011 and conclusion date of November 1, 2011. | Disclosed in part | 96 |
| A-2012-01203 | All correspondence concerning Visalus Sciences or one of its representatives. (Jan 1, 2009 to Nov 11, 2012). | Disclosed in part | 694 |
| A-2012-01425 | A summary of third party requests (members of the public or organizations) made to the Minister of Health requesting the cancellation of pesticide registrations and resulting actions". (Jan 1, 2005 to Jan 3, 2013). | Disclosed in part | 454 |
| A-2012-01427 | 2012 briefing notes, reports that lead to changing the supply systems of medical marihuana, including attendant problems with the current regulations. | Disclosed in part | 32 |
| A-2012-01469 | Documents December 16, 2012 announcement by minister Aglukkaq on proposed new marihuana for medical purposes regulation. | Disclosed in part | 355 |
| A-2012-01484 | List or summary of training courses taken by all Department employees, including supervisory staff, with details for each course, such as the cost, course title, name of the supplier and number of participants. (Jan 1, 2012 to Dec 31, 2012). | Disclosed in part | 339 |
| A-2012-01496 | All documents to brief Minister Leona Aglukkaq and/or Acting/Assistant Deputy Minister Kathy Langlois ahead of the January 11, 2013 meeting with Prime Minister Stephen Harper, Assembly of First Nations Chief Shawn Atleo and others. | Disclosed in part | 322 |
| A-2012-01497 | Contract/contribution agreement between Health Canada and Sioux Lookout First Nation Health Authority for the procurement of the new Hostel, completed in early 2011. | All disclosed | 95 |
| A-2012-01518 | AERs for the product BIAXIN. Report numbers: 000430542, 000434418, 000437259, 000443705 and 000451652. | Disclosed in part | 11 |
| A-2012-01519 | All e-mails sent or received by all staff within the office of the Minister and the Deputy Minister related to the National Aboriginal Health Organization (NAHO). (Jan 1, 2011 to Jan 28, 2013). | Disclosed in part | 104 |
| A-2012-01524 | All email correspondence to and/or from Mr. Patrick Fitch, Senior Labour Relations Advisor, Human Resources Services Directorate, Corporate Services Branch, mentioning the Ancien Group. (Jan 1, 2009 to Jan 17, 2013). | Disclosed in part | 29 |
| A-2012-01525 | All email correspondence to and/or from Mr. Patrick Fitch, Senior Labour Relations Advisor, Corporate Labour Relations, Human Resources Services Directorate, Corporate Services Branch, mentioning Joelle Fougere. (Jan 1, 2009 to Jan 17, 2013). | Disclosed in part | 29 |
| A-2012-01541 | All documents produced regarding 'energy shots' and/or 'energy drinks' produced during the week of February 8, 2013. | Disclosed in part | 82 |
| A-2012-01542 | Information regarding the product Keflex, DIN 00244392 and 00403628 by Pendopharm, Division of/de Pharmascience Inc. | Disclosed in part | 66 |
| A-2012-01552 | All correspondence from Ryan Johnstone, with respect to or making mention of the RedPath Mobile Addiction Treatment Program, Mobile Addiction Treatment, the RedPath Programs and training and/or Whitepath Inc. (Jan 1, 2012 to Jan 31,2013). | Disclosed in part | 65 |
| A-2012-01569 | All documents pertaining to any requests and/or applications for grants, honoraria, scholarships, or any other forms of funding made by Buffalo Point First Nation to Health Canada. (Oct 1, 1997 to Feb 15, 2013). | Disclosed in part | 221 |
| A-2012-01570 | All documents pertaining to any funding provided by Health Canada to Buffalo Point First Nation. (Feb, 16, 2008 to Feb, 15, 2013). | Disclosed in part | 1,380 |
| A-2012-01584 | All funding agreements/amendments pertaining to the Woodstock First Nation, New Brunswick. (Jan 1, 2005 to Feb, 19, 2013). | Disclosed in part | 914 |
| A-2012-01604 | AER for the product Yasmin. Report number: 000461530. | Disclosed in part | 2 |
| A-2012-01618 | AERs for the product Cymbalta. Report numbers: 000397830, 000381114, 000383893, 000386303, 000386480, 000400084, 000406744, 000414575, 000415548, 000416891 and 000417149. | Disclosed in part | 17 |
| A-2012-01623 | AERs for the product Cialis. Report numbers: 000398252, 000398551, 000404897, 000410975, 000415114, 000444890, 000444768, 000445407 and 000462209. | Disclosed in part | 31 |
| A-2012-01631 | AERs for the product Strattera. Report numbers: 000436065, 000442056, 000455392, 000461887, 000461909, 000461929 and 000462862. | Disclosed in part | 13 |
| A-2012-01647 | Information relating to the business activities of Enviroway Detergent Manufacturing Inc. | All disclosed | 13 |
| A-2012-01685 | All documents and analysis comparing and contrasting the Canadian, United States and other national standards systems, including relative competitive benefits and risks of each system. (Nov 1, 2011 to Feb 26, 2013). | Disclosed in part | 95 |
| A-2012-01687 | All records supporting the Standards Council of Canada's assertion in its Communique dated July 20, 2012 that a growing number of Canadians are participating directly in standards development activities outside of Canada. (Nov 1, 2011 to Feb 26, 2013). | Disclosed in part | 33 |
| A-2012-01739 | Documentation relating to Standing Offers Arrangements for French language training services, which could be used, or were used by Health Canada. (Mar 1, 2012 to Mar 15, 2013. | Disclosed in part | 299 |
| A-2012-01744 | All briefing material to the Deputy Minister regarding Information Technology (IT) Security, information management security, and cyber security. (Jan 1, 2012 to Mar 19, 2013). | Disclosed in part | 64 |
| A-2012-01748 | List of all contributions made by Health Canada related to Nutrition North Canada. (Apr 1, 2010 to Mar 15, 2013). | All disclosed | 2 |
| A-2012-01766 | Comments received in response to the October 25, 2012 information and notification document on Health Canada's proposal to enable the use of Dimethyl Dicarbonate as a preservative in wine and in unstandardized water based non-alcoholic beverages. | All disclosed | 4 |
| A-2013-00001 | Funding agreements between Health Canada and the Mental Health Commission of Canada. | All disclosed | 119 |
| A-2013-00005 | All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of March 2013. | Disclosed in part | 33 |
| A-2013-00009 | Documents indicating the number of medical marijuana grow licenses that were issued in 2012 of the following Municipalities/Villages and Districts: Resort Municipality of Whistler, Village of Pemberton, District of Squamish and Squamish Lillooet Regional District. | All disclosed | 1 |
| A-2013-00012 | List of authorized growers for Marihuana. | All disclosed | 1 |
| A-2013-00018 | A listing of the Access to Information requests submitted to Health Canada. (Mar 1, 2013 to Mar 31, 2013). | Disclosed in part | 9 |
| A-2013-00021 | All applications submitted for an exemption to the Controlled Drugs and Substances Act for operation of a supervised injection site in Toronto or Ottawa. (Jan 1, 2005 to Apr 11, 2013). | No records exist | 0 |
| A-2013-00024 | All documents showing the number of calls made to the emergency number of Health Canada's Health Products and Food Branch Inspectorate to report counterfeit bogus products, including, in particular, Botox and Juvederm fillers. (Mar 12, 2011 to Mar 11, 2013). | No records exist | 0 |
| A-2013-00025 | All correspondence between the Department of Health and Royal Canadian Mounted Police (RCMP) officials making reference to counterfeit products, such as Botox and Juvederm fillers. (Nov 1, 2012 to Apr 8, 2013). | No records exist | 0 |
| A-2013-00027 | Documents regarding a detailed budget of the Marihuana Medical Access Program from the beginning of the program's existence until fiscal year 2012-2013. | All disclosed | 2 |
| A-2013-00033 | Data showing the number of bogus (imitation) Botox products sold to Canadians and for which you have received complaints. (Jan 1, 2006 to Apr 15, 2013). | No records exist | 0 |
| A-2013-00034 | Complete copy of the most recent Health Canada reports on adverse reaction statements involving bogus or imitation Botox cosmetic products. (Jan 1, 2013 to Apr 15, 2013). | No records exist | 0 |
| A-2013-00039 | List of all contracts between Health Canada and Dr. Krewski. (Jan 1, 2007 to Apr 17, 2013). | All disclosed | 3 |
| A-2013-00042 | All health risk assessments completed in fiscal year 2012-13 by Health Canada in response to complaints regarding direct-to-consumer advertising of prescription and schedule D drug advertising. | No records exist | 0 |
| A-2013-00043 | Documents relating to the Advertising Advisory Opinion in fiscal year 2012-13. | No records exist | 0 |
| A-2013-00068 | A copy of a document titled Reporting on National Nuclear Emergency Preparedness prepared by International Safety Research. (Nov 7, 2012 to Apr 19, 2013). | No records exist | 0 |
| A-2013-00072 | AER for the product ACTOS. Report number: 000465276. | Disclosed in part | 2 |
| A-2013-00073 | AERs for the product Dexilant. Report numbers: 000453729, 000456200, 000461900, 000462813, 000467390, 000468708, 000476086, 000482366, 000484822 and 000460842. | Disclosed in part | 12 |
| A-2013-00074 | AER for the product Uloric. Report number: 000483490. | Disclosed in part | 3 |
| A-2013-00077 | AERs for the product Alvesco. Report numbers: 000450147, 000460718, 000471611 and 000487517. | Disclosed in part | 4 |
| A-2013-00078 | AER for the product Omnaris. Report number: 000470697. | Disclosed in part | 1 |
| A-2013-00079 | AERs for the product Daxas. Report numbers: 000448191 and 000458250. | Disclosed in part | 2 |
| A-2013-00081 | AERs for the product Adalat XL. Report numbers: 000475306 and 000476089. | Disclosed in part | 2 |
| A-2013-00082 | AERs for the product Avelox. Report numbers: 000475292, 000475558, 000476857 and 000476909. | Disclosed in part | 5 |
| A-2013-00083 | AERs for the product Gadovist. Report numbers: 000474371, 000477639, 000478022, 000478417 and 000480344. | Disclosed in part | 5 |
| A-2013-00084 | AERs for the product Magnevist. Report numbers: 000475719, 000476995 and 000480077. | Disclosed in part | 5 |
| A-2013-00085 | AERs for the product Mirena. Report numbers: 000478563, 000479979 and 000481057. | Disclosed in part | 3 |
| A-2013-00086 | AERs for the product Xarelto. Report numbers: 000474814 and 000479739. | Disclosed in part | 2 |
| A-2013-00087 | AERs for the product Yaz. Report numbers: 000474740, 000478894 and 000481466. | Disclosed in part | 3 |
| A-2013-00095 | AER for the product Pradax. | Disclosed in part | 1 |
| A-2013-00103 | Labelling standard for dental and oral care products for professional use-fluoride-varnish. | No records exist | 0 |
| A-2013-00106 | Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for: - Extractions; - Endodontic treatment (root canals). |
All disclosed | 1 |
| A-2013-00107 | Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for: - Average annual number of claims per claimant by age group; - Average annual cost per claimant by age group; - Total costs per year by age group; - Claimant rate by age group for preventative services. |
All disclosed | 11 |
| A-2013-00108 | Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for: - Orthodontic approval rates; - Appeals by class (first, second, and third) and by procedure (endodontic, orthodontic, restorative, prosthodontics). |
All disclosed | 2 |
| A-2013-00109 | Documents regarding dental services offered to Nunavut's Inuit population through the Non-Insured Health Benefits program between 1999 and 2012 for: - Nitrous oxide approval rates; - Number of children under the age of 12 who submitted eight or more claims for dental care benefits on the same day. |
All disclosed | 2 |
| A-2013-00113 | AERs for the product Celexa. Report numbers: 000478584 and 000485313. | Disclosed in part | 6 |
| A-2013-00114 | AER for the product Sabril. Report number: 000470377. | Disclosed in part | 1 |
| A-2013-00117 | The report created in August 1989 regarding the PCB (polychlorinated biphenyls) Study for Big Trout Lake / Weagamow Lake. | All disclosed | 36 |
| A-2013-00118 | Copy of Kitchenuhmaykoosib Sioux Lookout Zone Environmental Contaminants Health Study created by Health Canada in 1998. | All disclosed | 55 |
| A-2013-00119 | Documents regarding the nutrient intake of adults aged 15-65 for Big Trout Lake / Weagamow Lake. | Disclosed in part | 43 |
| A-2013-00120 | The Sioux Lookout Zone Environmental Contaminants Study - Kitchenuhmaykoosib created by Health Canada's First Nations and Inuit Health Branch in 2000. | All disclosed | 23 |
| A-2013-00124 | All call-ups processed by this institution in the National Capital Region under the terms of the ANY Standing Offer or Supply Arrangement for Temporary Help Services during the period of April 2013. | Disclosed in part | 97 |
| A-2013-00125 | Documentation which indicates all appointments term and casual employees by this institution in the National Capital Region under the term of the Public Service Employment Act during April 2013. | All disclosed | 3 |
| A-2013-00128 | AER. Report number: 000468298. | Disclosed in part | 1 |
| A-2013-00129 | AER. Report number: 000470244. | Disclosed in part | 1 |
| A-2013-00130 | AER. Report number: 000473631. | Disclosed in part | 1 |
| A-2013-00131 | AER. Report number: 000484939. | Disclosed in part | 1 |
| A-2013-00132 | AER. Report number: 000473945. | Disclosed in part | 1 |
| A-2013-00136 | AER. Report number: 000476035. | Disclosed in part | 1 |
| A-2013-00137 | AER. Report number: 000476083. | Disclosed in part | 1 |
| A-2013-00143 | AER. Report number: 000484303. | Disclosed in part | 1 |
| A-2013-00144 | AER. Report number: 000487347. | Disclosed in part | 1 |
| A-2013-00174 | Aggregated (non-identifying) data regarding the following information required to be reported by pharmacies to Health Canada pursuant to a Health Canada letter dated November 26, 2012: Sales reports of all controlled release formulations of oxycodone products and reports of unusual orders involving controlled release formulations of Oxycodone products. | No records exist | 0 |
| A-2013-00175 | All documents relating to the construction, maintenance, abatement, decommissioning or operation of the TransCanada pipeline. | No records exist | 0 |
| A-2013-00176 | Data or statistics about asbestos or silica exposure or rates of mesothelioma in relation to TransCanada pipeline workers. | No records exist | 0 |
| A-2013-00177 | Regulatory approvals related to the TransCanada pipeline, including but not limited to regulatory documents related to air quality or the use of silica or asbestos. | No records exist | 0 |
| A-2013-00178 | All Industrial hygiene reports, dust reports, air sampling, safety complaints or inspections related to respiratory or air quality conditions or the use of silica or asbestos, in relation to the TransCanada pipeline. | No records exist | 0 |
| A-2013-00179 | All correspondence related to Anova Food or Clearsmoke Technologies. (Jan 1, 2011 to Apr 29, 2013). | No records exist | 0 |
| A-2013-00182 | All letters of advisory opinion issued with respect to enzymes or enzyme preparations by Health Canada. (Apr 1, 2004 to Mar 31, 2007). | No records exist | 0 |
| A-2013-00185 | All letters of advisory opinion issued with respect to enzymes or enzyme preparations by Health Canada. (Apr 1, 2000 to Mar 31, 2004). | No records exist | 0 |
| A-2013-00248 | Information on Medtronic CoreValve interim analysis (30 days) from the ongoing United States Investigational Device Exemption study. | No records exist | 0 |